Safety and Efficacy of Intermittent High-Dose Liposomal Amphotericin B Antifungal Prophylaxis in Haemato-Oncology: An Eight-Year Single-Centre Experience and Review of the Literature

Safety and Efficacy of Intermittent High-Dose Liposomal Amphotericin B Antifungal Prophylaxis in Haemato-Oncology: An Eight-Year Single-Centre Experience and Review of the Literature

<b> </b>Triazoles remain first-line agents for antifungal prophylaxis in high-risk haemato-oncology patients, but their use is increasingly contraindicated due to drug–drug interactions and additive toxicities with novel treatments. In this retrospective, single-centre, observational stu...

Full description

Bibliographic Details
Main Authors: Jonathan Youngs, Jen Mae Low, Laura Whitney, Clare Logan, Janice Chase, Ting Yau, Matthias Klammer, Mickey Koh, Tihana Bicanic
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Journal of Fungi
Subjects:
hematopoietic stem-cell transplantation (HSCT), acute leukaemia
graft-versus-host disease (GvHD), antifungal prophylaxis
amphotericin B
triazoles
Online Access:https://www.mdpi.com/2309-608X/6/4/385

Internet

https://www.mdpi.com/2309-608X/6/4/385

Similar Items